Sk. Roy et al., Bleomycin-induced chromosome damage in lymphocytes indicates inefficient DNA repair capacity in breast cancer families, J EXP CL C, 19(2), 2000, pp. 169-173
Citations number
29
Categorie Soggetti
Oncology
Journal title
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
In vitro mutagen susceptibility has been observed as a predictor of cancer
risk. To evaluate susceptibility to mutagen, we have studied the response t
o in vitro bleomycin (BLM) treatment in cultured peripheral blood lymphocyt
es (PBL) of 9 breast cancer families (BCFs). Eleven breast cancer patients
(BCPs) and 36 healthy blood relatives (HBRs) from BCFs were included in the
study. Data were compared with 22 healthy control women. The frequencies o
f chromosomal aberrations were evaluated after exposure to BLM in the last
five hours. Mean frequency of BLM-induced chromosomal aberrations per cell
(CA) observed among BCPs was significantly higher as compared to their HBRs
as well as control subjects. Moreover, mean BLM-induced CA/cell value obse
rved for HBRs was also significantly higher than that of control subjects.
In comparison to controls, it was observed that there was four times more c
ancer risk in BCPs (OR=4.148, 95% CI=5.83-687.46) and 2.5 times more cancer
risk in HBRs (OR=2.67, 95% CI=5.31-39.25). Lymphocytes from 90% of BCPs an
d 69% of HBRs were found to he sensitive to BLM (using a cutoff value = con
trols group mean + 1SD). Thus, lymphocytes of BCPs and their HBRs were more
sensitive to BLM exposure as compared to controls. Our finding indicated i
nefficient DNA repair capacity in BCFs. The HBRs in BCFs, having increased
BLM-sensitivity, may be at higher risk to develop a similar cancer.